Brickell Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brickell Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brickell Biotech in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.010.157.82
Details
Intrinsic
Valuation
LowReal ValueHigh
0.061.118.78
Details
Naive
Forecast
LowNext ValueHigh
0.0032040.167.83
Details
1 Analysts
Consensus
LowTarget PriceHigh
4.004.004.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brickell Biotech. Your research has to be compared to or analyzed against Brickell Biotech's peers to derive any actionable benefits. When done correctly, Brickell Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brickell Biotech.

Brickell Biotech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Brickell Biotech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Brickell and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Brickell Biotech does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Brickell Biotech Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Brickell Biotech stock performing well and Brickell Biotech company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Brickell Biotech's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
BLI 5.73 (0.17)  0.00 (0.17)  0.00 (0.0423)  0.00  13.15 (10.02)  41.58 
BLU 3.62  0.47  0.08  0.22  4.84  0.09 (3.74)  6.84 (7.43)  27.61 
MBIO 4.95  0.00  0.00 (0.10)  0.00 (0.0246)  0.00  10.98 (8.57)  33.47 
BBIO 5.06  0.15  0.00 (0.03)  0.00  0.0034  0.00  10.78 (10.79)  30.73 
BTX 3.64 (1.53)  0.00 (0.97)  0.00 (0.33)  0.00  5.88 (10.22)  24.69 
MBRX 2.84  0.15  0.04  0.02  3.50  0.0335 (3.39)  6.04 (6.11)  23.37 
FOLD 3.20 (0.01)  0.00 (0.11)  0.00 (0.0136)  0.00  6.15 (6.07)  22.29 
BCAB 4.85 (1.18)  0.00 (0.56)  0.00 (0.18)  0.00  9.77 (9.84)  53.53 
BCDA 4.36 (0.16)  0.00 (0.21)  0.00 (0.0367)  0.00  8.81 (11.94)  23.52 

Cross Equities Net Income Analysis

Compare Brickell Biotech and related stocks such as Berkeley Lights, Bellus Health, Mustang Bio, Bridgebio Pharma, Brooklyn Immunotherapeuti, Moleculin Biotech, Amicus Therapeutics, Bioatla, and Biocardia Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
BLI(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(23.3 M)(18.3 M)(41.6 M)(71.7 M)(73.6 M)
BLU(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(1.9 M)(9.1 M)(26 M)(31.8 M)(71.2 M)(73.1 M)
MBIO(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(12.7 M)(31.3 M)(30.7 M)(46.4 M)(60 M)(66.4 M)(68.1 M)
BBIO(30.6 M)(30.6 M)(30.6 M)(30.6 M)(30.6 M)(30.6 M)(30.6 M)(30.6 M)(130.7 M)(260.6 M)(448.7 M)(562.5 M)(577.3 M)
BTX(3.4 M)(3.4 M)(995 K)(1.1 M)(5 M)(7.2 M)(2.9 M)(1.1 M)(259 K)(2 M)(26.5 M)(122.3 M)(125.5 M)
MBRX(1.8 M)(1.8 M)(1.8 M)(1.8 M)(1.8 M)(365.8 K)(3.9 M)(9.8 M)(11.9 M)(13.2 M)(17.4 M)(15.9 M)(16.3 M)
FOLD(44.4 M)(44.4 M)(48.8 M)(59.6 M)(68.9 M)(132.1 M)(200 M)(284 M)(349 M)(356.4 M)(276.9 M)(250.5 M)(270.2 M)
BCAB(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29 M)(29.8 M)(35.9 M)(95.4 M)(97.9 M)
BCDA9.7 M9.7 M305 K19 K234 K(6.7 M)(10.3 M)(12.3 M)(14 M)(14.7 M)(15 M)(12.6 M)(13 M)

Brickell Biotech and related stocks such as Berkeley Lights, Bellus Health, Mustang Bio, Bridgebio Pharma, Brooklyn Immunotherapeuti, Moleculin Biotech, Amicus Therapeutics, Bioatla, and Biocardia Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Brickell Biotech financial statement analysis. It represents the amount of money remaining after all of Brickell Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends Income Statement Impact.

Brickell Biotech Competitive Analysis

The better you understand Brickell Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Brickell Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Brickell Biotech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
BBIBLIBLUMBIOBBIOBTXMBRXFOLDBCABBCDA
 6.25 
 0.15 
Brickell
 2.30 
 4.45 
Berkeley
 3.22 
 7.81 
Bellus
 4.55 
 0.63 
Mustang
 0.89 
 6.66 
Bridgebio
 7.58 
 0.61 
Brooklyn
 3.76 
 1.38 
Moleculin
 0.40 
 7.56 
Amicus
 5.16 
 2.24 
Bioatla
 1.94 
 1.58 
Biocardia
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Current Valuation
Cash Flow from Operations
Operating Margin
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Price to Earnings To Growth
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Brickell Biotech Competition Performance Charts

Complement your Brickell Biotech position

In addition to having Brickell Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Retail Thematic Idea Now

Retail
Retail Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
View All  Next Launch Retail
Continue to Brickell Biotech Correlation with its peers. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Brickell Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BBI -  USA Stock  

USD 0.15  0.01  6.25%

Brickell Biotech competes with Berkeley Lights, Bellus Health, Mustang Bio, Bridgebio Pharma, and Brooklyn Immunotherapeuti; as well as few others. The company runs under null sector within null industry. Analyzing Brickell Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Brickell Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Brickell Biotech competition on your existing holdings. Continue to Brickell Biotech Correlation with its peers.
  
Refresh
The current Return on Invested Capital is estimated to increase to 16.65, while Return on Average Assets are projected to decrease to (1.33) . Brickell Biotech Assets Non Current are most likely to decrease significantly in the upcoming years. The last year's value of Assets Non Current was reported at 117,000. The current Goodwill and Intangible Assets is estimated to increase to about 407.3 K, while Return on Average Assets are projected to decrease to (1.33) .